Literature DB >> 27010645

Intersubunit interactions at putative sites of ethanol action in the M3 and M4 domains of the NMDA receptor GluN1 and GluN2B subunits.

Y Zhao1, H Ren1, R W Peoples1.   

Abstract

BACKGROUND AND
PURPOSE: The NMDA receptor is an important target of alcohol action in the brain. Recent studies in this laboratory have demonstrated that alcohol-sensitive positions in the intersubunit interfaces of the M3 and M4 domains of GluN1 and GluN2A subunits interact with respect to ethanol sensitivity and receptor kinetics and that alcohol-sensitive positions in the M domains of GluN2A and GluN2B subunits differ. In this study, we tested for interactions among alcohol-sensitive positions at the M domain intersubunit interfaces in GluN1/GluN2B NMDA receptors. EXPERIMENTAL APPROACH: We used whole-cell patch-clamp recording in tsA201 cells expressing tryptophan substitution mutants at ethanol-sensitive positions in the GluN1 and GluN2B NMDA receptor subunits to test for interactions among positions. KEY
RESULTS: Six pairs of positions in GluN1/GluN2B significantly interacted to regulate ethanol inhibition: Gly(638) /Met(824) , Gly(638) /Leu(825) , Phe(639) /Leu(825) , Phe(639) /Gly(826) , Met(818) /Phe(637) and Val(820) /Phe(637) . Tryptophan substitution at Met(824) or Leu(825) in GluN2B did not alter ethanol sensitivity but interacted with positions in the GluN1 M3 domain to regulate ethanol action, whereas tryptophan substitution at Gly(638) , which is the cognate of an ethanol-sensitive position in GluN2A, did not alter ethanol sensitivity or interact with positions in GluN1. Two and three pairs of positions interacted to regulate glutamate steady-state and peak current EC50 , respectively, and one pair interacted with respect to macroscopic desensitization.
CONCLUSIONS: Despite highly-conserved M domain sequences and similar ethanol sensitivity in the GluN2A and GluN2B subunits, the manner in which these subunits interact with the GluN1 subunit to regulate ethanol sensitivity and receptor kinetics differs.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27010645      PMCID: PMC4882498          DOI: 10.1111/bph.13487

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  55 in total

Review 1.  Ionotropic glutamate receptors as sites of action for ethanol in the brain.

Authors:  J J Woodward
Journal:  Neurochem Int       Date:  1999-08       Impact factor: 3.921

2.  A site in the fourth membrane-associated domain of the N-methyl-D-aspartate receptor regulates desensitization and ion channel gating.

Authors:  Hong Ren; Yumiko Honse; Brian J Karp; Robert H Lipsky; Robert W Peoples
Journal:  J Biol Chem       Date:  2002-10-31       Impact factor: 5.157

Review 3.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

4.  The NR1 M3 domain mediates allosteric coupling in the N-methyl-D-aspartate receptor.

Authors:  Marie L Blanke; Antonius M J VanDongen
Journal:  Mol Pharmacol       Date:  2008-05-15       Impact factor: 4.436

5.  Experimental design and analysis and their reporting: new guidance for publication in BJP.

Authors:  Michael J Curtis; Richard A Bond; Domenico Spina; Amrita Ahluwalia; Stephen P A Alexander; Mark A Giembycz; Annette Gilchrist; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Andrew J Lawrence; David J MacEwan; Lawrence D F Moon; Sue Wonnacott; Arthur H Weston; John C McGrath
Journal:  Br J Pharmacol       Date:  2015-07       Impact factor: 8.739

6.  Ethanol potentiates and blocks NMDA-activated single-channel currents in rat hippocampal pyramidal cells.

Authors:  M T Lima-Landman; E X Albuquerque
Journal:  FEBS Lett       Date:  1989-04-10       Impact factor: 4.124

Review 7.  Alcoholism: allostasis and beyond.

Authors:  George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

8.  Ethanol inhibits alpha-amino-3-hydyroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function in central nervous system neurons by stabilizing desensitization.

Authors:  Tommi Möykkynen; Esa R Korpi; David M Lovinger
Journal:  J Pharmacol Exp Ther       Date:  2003-05-06       Impact factor: 4.030

Review 9.  The NR2B subtype of NMDA receptor: a potential target for the treatment of alcohol dependence.

Authors:  Jozsef Nagy
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2004-06

10.  Coupling of agonist binding to channel gating in the GABA(A) receptor.

Authors:  Thomas L Kash; Andrew Jenkins; Jill C Kelley; James R Trudell; Neil L Harrison
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

View more
  5 in total

1.  Positions in the N-methyl-D-aspartate Receptor GluN2C Subunit M3 and M4 Domains Regulate Alcohol Sensitivity and Receptor Kinetics.

Authors:  Man Wu; Priya Katti; Yulin Zhao; Robert W Peoples
Journal:  Alcohol Clin Exp Res       Date:  2019-04-30       Impact factor: 3.455

2.  The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.

Authors:  Kiran Sapkota; Kim Dore; Kang Tang; Mark Irvine; Guangyu Fang; Erica S Burnell; Roberto Malinow; David E Jane; Daniel T Monaghan
Journal:  Biochem Pharmacol       Date:  2018-11-29       Impact factor: 5.858

3.  Intersubunit interactions at putative sites of ethanol action in the M3 and M4 domains of the NMDA receptor GluN1 and GluN2B subunits.

Authors:  Y Zhao; H Ren; R W Peoples
Journal:  Br J Pharmacol       Date:  2016-05-06       Impact factor: 8.739

Review 4.  Titrating Tipsy Targets: The Neurobiology of Low-Dose Alcohol.

Authors:  Changhai Cui; George F Koob
Journal:  Trends Pharmacol Sci       Date:  2017-03-31       Impact factor: 14.819

Review 5.  Understanding ethanol's acute effects on medial prefrontal cortex neural activity using state-space approaches.

Authors:  Mitchell D Morningstar; William H Barnett; Charles R Goodlett; Alexey Kuznetsov; Christopher C Lapish
Journal:  Neuropharmacology       Date:  2021-09-01       Impact factor: 5.273

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.